VOLPI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 27.566
EU - Europa 13.306
AS - Asia 5.180
SA - Sud America 239
AF - Africa 85
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 32
Totale 46.480
Nazione #
US - Stati Uniti d'America 27.428
GB - Regno Unito 5.209
IT - Italia 2.640
CN - Cina 1.627
SE - Svezia 1.567
SG - Singapore 1.299
DE - Germania 953
UA - Ucraina 938
TR - Turchia 796
HK - Hong Kong 626
FI - Finlandia 476
BG - Bulgaria 388
FR - Francia 319
KR - Corea 175
IN - India 141
BR - Brasile 115
ES - Italia 102
VN - Vietnam 97
RU - Federazione Russa 91
ID - Indonesia 90
PL - Polonia 85
CH - Svizzera 81
IE - Irlanda 77
JP - Giappone 74
CA - Canada 73
NL - Olanda 64
AU - Australia 60
MX - Messico 56
IR - Iran 55
MY - Malesia 44
GR - Grecia 43
AR - Argentina 42
TH - Thailandia 42
BE - Belgio 36
PE - Perù 33
RO - Romania 33
CZ - Repubblica Ceca 29
LT - Lituania 29
RS - Serbia 28
PT - Portogallo 27
PK - Pakistan 26
EU - Europa 25
CL - Cile 20
DK - Danimarca 19
EG - Egitto 19
PH - Filippine 17
TN - Tunisia 17
ZA - Sudafrica 15
DZ - Algeria 14
CO - Colombia 13
IL - Israele 12
NZ - Nuova Zelanda 12
SI - Slovenia 12
TW - Taiwan 12
MA - Marocco 11
NO - Norvegia 11
EC - Ecuador 10
HR - Croazia 8
SK - Slovacchia (Repubblica Slovacca) 8
HU - Ungheria 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AT - Austria 6
UZ - Uzbekistan 6
AL - Albania 5
BD - Bangladesh 5
BO - Bolivia 5
MO - Macao, regione amministrativa speciale della Cina 5
SY - Repubblica araba siriana 5
CU - Cuba 4
IQ - Iraq 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
JO - Giordania 3
MK - Macedonia 3
NG - Nigeria 3
PA - Panama 3
SM - San Marino 3
UG - Uganda 3
AM - Armenia 2
BJ - Benin 2
BY - Bielorussia 2
CR - Costa Rica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
OM - Oman 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
EE - Estonia 1
IM - Isola di Man 1
KW - Kuwait 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 46.480
Città #
Southend 4.419
Fairfield 3.402
Woodbridge 2.606
Ashburn 2.161
Chandler 2.100
Houston 2.048
Jacksonville 1.993
Dearborn 1.557
Santa Clara 1.455
Seattle 1.206
Wilmington 1.188
Ann Arbor 1.185
Cambridge 1.101
Singapore 970
Nyköping 950
Hong Kong 615
Beijing 591
Modena 430
Princeton 414
Sofia 373
Izmir 365
Eugene 356
San Diego 329
New York 284
Redwood City 220
Milan 200
Helsinki 160
London 144
Des Moines 123
Rome 104
Falls Church 84
Dong Ket 80
Shanghai 73
Jakarta 65
Dublin 62
Bologna 60
Hefei 60
Norwalk 60
Boardman 51
Nanjing 51
Naples 48
Istanbul 47
Madrid 46
Kunming 41
Jinan 34
Toronto 34
Florence 33
Guangzhou 33
Kilburn 32
Verona 31
Seoul 29
Brussels 28
Nanchang 27
Turin 27
Bangkok 26
Parma 25
Perugia 25
Belgrade 24
Chiswick 24
Frankfurt am Main 23
Hounslow 23
Munich 23
Fremont 22
Los Angeles 22
Paris 22
Tokyo 21
Dallas 19
San Mateo 19
Auburn Hills 18
Indiana 18
Kraków 18
Mountain View 18
Philadelphia 18
Saint Petersburg 18
Zhengzhou 18
Amsterdam 17
Buenos Aires 17
Chicago 17
Chongqing 17
Ottawa 17
San Francisco 17
Stockholm 17
Sydney 17
Athens 16
Dongguan 16
Monterrey 16
Prescot 16
Ankara 15
Atlanta 15
Barcelona 15
Bari 15
Caserta 15
Padova 15
San Giuliano Milanese 15
Seongnam-si 15
Torino 15
Brescia 14
Delhi 14
Jiaxing 14
Phoenix 14
Totale 35.020
Nome #
BIOCHIMICA STRUTTURALE, FUNZIONALE E METABOLICA 778
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 517
Two analytical approaches to the evaluation of chondroitin sulfate in european food supplements. 451
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 392
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 343
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 316
ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly 316
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 272
A 96-well assay for uronic acid carbazole reaction 256
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 237
Le arilsolfatasi come glicoconiugati: aspetti biochimico - comparati della loro regolazione 225
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 224
12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment. 223
Chondroitin Sulfate and Glucosamine as Disease Modifying Anti- Osteoarthritis Dru gs (DMOADs). 220
Plasmatic and urinary glycosaminoglycans characterization in mucopolysaccharidosis II Patient treated with enzyme-replacement therapy with Idursulfase 214
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 213
Isolation and structural characterization of chondroitin sulfate from bony fishes 205
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 205
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 204
Glycosaminoglycan Blotting and Detection After Electrophoresis Separation 204
Capillary blotting of glycosaminoglycans on nitrocellulose membranes after agarose-gel electrophoresis separation 204
Beta-amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease. 203
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 194
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 192
Recent advances on separation and characterization of human milk oligosaccharides. 189
Human Milk Glycosaminoglycans Inhibit in vitro the Adhesion of Escherichia coli and Salmonella fyris to Human Intestinal Cells 188
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 187
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 182
Electrophoresis for the analysis of heparin purity and quality. 180
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and Low molecular weight-heparins disaccharides and oligosaccharides. 180
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 180
Capillary electrophoresis of bacterial (lipo)polysaccharides 180
Composition and structure elucidation of human milk glycosaminoglycans 179
I glicosaminoglicani: struttura, funzioni, tecniche analitiche di indagine, e loro modificazioni in valvole mitraliche ed aortiche di soggetti affetti da patologia degenerativa 179
Chondroitin sulfate structure is modified in human milk produced by breast affected by invasive carcinoma. 179
Shift of optimal pH in arylsulphatase from Mollusca depending on temperature 178
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 178
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 177
Shockwave lithotripsy and the protective role of inosine: Early and late evaluation in an experimental model 177
Adsorption of glycosaminoglycans onto coral - a new possible implant biomaterials for regeneration therapy 176
Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations 176
Separation of flavonoids and phenolic acids from propolis by capillary zone electrophoresis 175
Comparative analysis of fatty acid profile in three eutardigrade species 175
Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients 171
effects of glycosaminoglycans on u-937 leukemia-cell proliferation and differentiation - structure-function relationship 169
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 169
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 169
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for early diagnosis application 168
Determination of urinary hexosamines for diagnosis of bladder pain syndrome 167
Human milk glycosaminoglycans: the state of the art and future perspectives 167
Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cell carcinoma 166
Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry 165
High-performance capillary electrophoresis separation of hyaluronan oligosaccharides produced by Streptomyces hyalurolyticus hyaluronate lyase 164
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 164
Electrophoretic approaches to the analysis of complex polysaccharides 163
Different analyses measure chondroitin pharmacokinetics. 163
Glycosaminoglycan content in term and preterm milk during the first month of lactation 162
Safety assessment of non-animal chondroitin sulfate sodium: Subchronic study in rats, genotoxicity tests and human bioavailability. 162
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 162
activity of chondroitin ABC lyase on dermatan sulfate partially degraded by cupric-ion-mediated free-radical treatment 161
Stability studies of chondroitin sulfate 161
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 160
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 160
Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses 160
On-line high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry profiling of human milk oligosaccharides derivatized with 2-aminoacridone 159
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 158
Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses 158
Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects 158
Studies on European eel skin sulfated glycosaminoglycans: Recovery, structural characterization and anticoagulant activity 158
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 157
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 157
Effect of nonanimal high- and low-molecular-mass chondroitin sulfates produced by a biotechnological process in an animal model of polyarthritis 156
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease. 155
Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE) 155
The protein profile of fibroblasts: the role of proteomics. 155
Analytical aspects of pharmaceutical grade chondroitin sulfates 155
Effect of holder pasteurisation on human milk glycosaminoglycans 155
Hyaluronan in medical practice 154
Direct and specific recognition of glycosaminoglycans by antibodies after their separation by agarose gel electrophoresis and blotting on cetylpyridinium chloride-treated nitrocellulose membranes 154
Oral bioavailability of chondroitin sulfate (Condrosulf (R)) and its constituents in healthy male volunteers 153
Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site 153
Human milk glycosaminoglycans in feces of breastfed newborns: preliminary structural elucidation and possible biological role 153
Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model 153
Localization and expression of CHST6 and keratan sulfate proteoglycans in the human cornea 153
Anti-zika virus and anti-usutu virus activity of human milk and its components 153
Influence of charge density, sulfate group position and molecular mass on adsorption of chondroitin sulfate onto coral 152
Purification and characterization of hyaluronic acid from the mollusc bivalve Mytilus galloprovincialis 152
Composition of urinary glycosaminoglycans in a patient with pseudoxanthoma elasticum and familial Mediterranean fever 152
Regulation of arylsulphatases: inhibition of arylsulphatase from Haliotis rufusensis by phosphoric esters and shift of optimal pH depending on temperature 152
EFFECTS OF LOW-POWER 632 NM RADIATION (HENE LASER) ON A HUMAN CELL-LINE - INFLUENCE ON ADENYLNUCLEOTIDES AND CYTOSKELETAL STRUCTURES 151
Simultaneous detection of submicrogram quantities of hyaluronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and Stains-All 151
Characterization of a low-sulfated chondroitin sulfate isolated from the hemolymph of the freshwater snail Planorbarius corneus. 151
Recenti approcci analitici per la valutazione della qualità della propoli 151
Evaluation of chondroitin sulfate bioactivity in hippocampal neurones and the astrocyte cell line U373: Influence of position of sulfate groups and charge density 151
Disaccharide mapping of chondroitin sulfate of different origins by high-performance capillary electrophoresis and high-performance liquid chromatography 149
Effect of low-frequency electromagnetic pulsed field stimulation on yeast fermentation in presence of dicarboxylic and tricarboxylic acids 149
IMPLICANCIA DE LAS CADENAS DE GLICOSAMINOGLICANOS DE LA MATRIZ EXTRACELULAR EN LA “ATERO-RESISTENCIA” VASCULAR. 149
Chondroitin sulfate in normal human plasma is modified depending on the age. Its evaluation in patients with pseudoxanthoma elasticum 148
Chondroitin Sulfate Effect On Induced Arthritis In Rats 148
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier 148
Totale 19.192
Categoria #
all - tutte 187.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.968 0 0 0 0 1.113 1.363 1.369 1.108 729 379 554 353
2020/20217.428 1.145 230 492 506 675 825 663 880 358 843 434 377
2021/20225.728 214 844 516 425 158 312 312 251 718 462 801 715
2022/20236.174 692 581 425 543 684 905 183 688 819 74 285 295
2023/20244.542 227 281 197 571 1.042 351 394 584 128 134 213 420
2024/20253.608 518 194 225 969 1.702 0 0 0 0 0 0 0
Totale 46.901